94 results
Page 2 of 5
6-K
EX-99.1
ce3 m7fpltlx
20 Jun 23
Current report (foreign)
5:53pm
6-K
EX-99.1
sij y5pxl
1 May 23
Current report (foreign)
8:00am
6-K
EX-99.1
eidcm7o2og
30 Nov 22
Current report (foreign)
9:08pm
6-K
EX-99.1
mtq3ooiodlqdxn
29 Nov 22
Current report (foreign)
4:58pm
6-K
EX-99.2
s8yapr0
29 Nov 22
Current report (foreign)
4:58pm
6-K
EX-99.1
ocihvgnvjr0g7x dvok9
14 Sep 22
Current report (foreign)
10:31am
6-K
EX-99.1
g0dflzau2oyd9ef
29 Aug 22
Current report (foreign)
4:00pm
6-K
EX-99.2
tagg 10ewpaztm888b
29 Aug 22
Current report (foreign)
4:00pm
424B5
lvbubgb
19 Aug 22
Prospectus supplement for primary offering
10:52am
6-K
EX-99.1
uj2riyca
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
6-K
EX-99.2
tikdm4dy gulst
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
f379ll
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
v2zrvc
30 Aug 21
Current report (foreign)
5:21pm
6-K
EX-99.1
nmnbacr66gw
12 Aug 21
Portage Biotech Issues Letter to Shareholders
10:01am
SUPPL
pwmawsegw7kwbb8nah
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
xun3nqykp4gu1
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B2
hdnktpn5e 63tan
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.2
8trht8di
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm